Company
United StatesPublic company, NYSE: MDTMedtronic Inc. (NYSE: MDT), Minneapolis, MN – FDA Inspections
Inspection records and compliance data for Medtronic Inc. in Minneapolis, Minnesota. 3 FDA inspections on record, last inspected November 13, 2017. Publicly traded as NYSE: MDT.
Company Profile
This profile covers Medtronic Inc. based in Minneapolis, Minnesota, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 2
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected October 22, 2010. Last inspected November 13, 2017.
Most cited issue areas
- No approval for changes requiring prior approval1 inspection
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| November 13, 2017 | Not classified | Medical Devices & Rad Health | 1045908 |
| December 8, 2011 | VAI | Medical Devices & Rad Health · Bioresearch Monitoring | 755963 |
| October 22, 2010 | VAI | Medical Devices & Rad Health · Bioresearch Monitoring | 694569 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Medtronic Inc.
Stock ticker
MDT
Exchange
NYSE
Share price
$105.03
Market cap
$134.3B
Price as of
November 6, 2026
FEI Number
3008114455
Address
3033 Campus Dr, Minneapolis, Minnesota 55441, United States
Country
United States
ID: 52cb88b4-3265-4600-88de-dc3478287eaa